Ercem Atillasoy - 21 Oct 2021 Form 4 Insider Report for Allovir, Inc. (KLRS)

Signature
/s/ Brett Hagen, as Attorney-in-Fact
Issuer symbol
KLRS
Transactions as of
21 Oct 2021
Net transactions value
-$36,690
Form type
4
Filing time
25 Oct 2021, 16:12:44 UTC
Next filing
04 Apr 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALVR Common Stock Sale $36,690 -1,514 -1.4% $24.23* 104,986 21 Oct 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock, and does not represent a discretionary trade by the reporting person.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.51. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Remarks:

Officer Title: Chief Regulatory and Safety Officer